Neurofluxa behavioral health company, secured a $25 million investment led by growth equity impact investor SEMCAP Health, bringing its total funding to $32 million.
The company raised $7.5 million in a Series A funding round in 2019 and $20 million in Series B financing in 2021.
WHAT THEY DO
NeuroFlow’s cloud-based platform enables healthcare providers to track, assess and connect with patients between traditional office visits. The company also offers AI-powered clinical decision support with recommendations for next steps for individual patients.
The Pennsylvania-based company will use the funds to expand its network and increase R&D investments to grow its platform. It will also increase its headcount in all departments.
“We are excited to bring on board a strong partner like SEMCAP to support our next stage of growth. This gives us the opportunity to meet the demand we are experiencing and invest in a platform that helps deliver a happier, healthier quality of life for those in the full spectrum of mental health needs. With this funding, we will focus on strategic hiring, R&D for the platform, and launching a Spanish-language app,” said James Kanka, Vice President of Marketing at NeuroFlow. MobiHealthNews in an email.
MARKET SNAPSHOT
Last month, NeuroFlow announced a collaboration with Cirrus MDa startup offering text-on-demand telehealth, where CirrusMD would leverage NeuroFlow’s clinical decision support platform, patient engagement tools, and intervention services.
In February, Neuroflux announced an alliance with Aflacproviding insurance provider employees with access to digital mental health resources through NeuroFlow’s educational content service.
